FWM
DFTX

Focused Wealth Management’s Definium Therapeutics DFTX Stock Holding History

Focused Wealth Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10
Closed -$37 – 651
2023
Q4 		$37 Hold
10
– – ﹤0.01% 998
2023
Q3 		$31 Hold
10
– – ﹤0.01% 1011
2023
Q2 		$36 Hold
10
– – ﹤0.01% 1045
2023
Q1 		$32 Hold
10
– – ﹤0.01% 1025
2022
Q4 		$22 Hold
10
– – ﹤0.01% 1071
2022
Q3 		$0 Sell
10
-1
-9% -$10 ﹤0.01% 1006
2022
Q2 		$0 Hold
11
– – ﹤0.01% 1016
2022
Q1 		$0 Hold
11
– – ﹤0.01% 1055
2021
Q4 		$0 Hold
11
– – ﹤0.01% 1058
2021
Q3 		$0 Hold
11
– – ﹤0.01% 1065
2021
Q2 		$1K Buy
+11
New +$577 ﹤0.01% 877

Other funds holding DFTX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Focused Wealth Management's DFTX Position: Q1 2024 in Review

Focused Wealth Management sold out of Definium Therapeutics (DFTX) in Q1 2024, closing a stake of 10 shares — an estimated $37 sold.

Focused Wealth Management first reported a position in DFTX in Q2 2021 and held it in 11 quarters. The position peaked at $1K in Q2 2021. 135 funds tracked by Wall St. Rank hold DFTX as of Q1 2024.

  • Focused Wealth Management reported no remaining Definium Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Focused Wealth Management sold 10 Definium Therapeutics shares in Q1 2024, an estimated $37.
  • Focused Wealth Management first reported a position in Definium Therapeutics in Q2 2021 and held it in 11 quarters.
  • Focused Wealth Management's Definium Therapeutics position peaked at $1K in Q2 2021.
  • 135 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.